Navigation Links
Sinovac Holds 2010 Annual Meeting of Shareholders
Date:7/15/2010

BEIJING, July 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it held its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted in person or by proxy. The meeting was held concurrently at No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's, Antigua.

During the meeting, the three proposals that required the affirmative vote of a majority of the shares cast were approved as follows: all of the directors were re-elected; the audited consolidated financial statements for financial year ended December 31, 2009 were approved and the selection of Ernst & Young as independent auditors was confirmed. The three proposals, which related to amending the Company's by-laws and required the affirmative vote of a majority of common shares outstanding, were not approved.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). PanfluTM, Sinovac's pandemic influenza vaccine (H5N1), has already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines. Its 30%-owned joint venture, Sinovac Dalian, focuses on the research, development, manufacturing and commercialization of vaccines, such as rabies, chickenpox, mumps and rubella vaccines for human use.

    For more information, please contact:

     Chris Lee
     Sinovac Biotech Ltd.
     Tel:   +86-10-8279-9659
     Fax:   +86-10-6296-6910
     Email: lill@sinovac.com

    Investors:
     Amy Glynn/Stephanie Carrington
     The Ruth Group
     Tel:   +1-646-536-7023/7017
     Email: aglynn@theruthgroup.com
            scarrington@theruthgroup.com

    Media
     Jason Rando
     The Ruth Group
     Tel:   +1-646-536-7025
     Email: jrando@theruthgroup.com


'/>"/>
SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sinovac Schedules 2010 Annual Meeting of Shareholders
2. Sinovac Selected by Beijing CDC to Supply Hepatitis A Vaccine Healive(R)
3. Sinovac Announces Plan to Launch Offering of Common Shares
4. Sinovac Announces Recent Developments
5. Sinovac Obtains Fifth H1N1 Vaccine Order from Chinese Central Government
6. Sinovac Named One of Chinas Top 10 Most Competitive Companies Listed Overseas in 2009
7. Sinovacs CEO Weidong Yin Nominated for China Central Televisions Prestigious Economic Man-of-the-Year Award
8. Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government
9. Sinovac Files Shelf Registration Statement
10. Sinovacs PANFLU.1 (H1N1) Regulatory Approval Expanded to Include Geriatric Population
11. Sinovac Receives Purchase Order from Shanghai Government to Supply Hepatitis A Vaccine Healive(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... you know that PhRMA member companies invested $65.5 billion in research ... medicines, generics and the supply chain account for 14 percent of ... this (7 percent)? Or that the United States ... in high-growth biopharmaceutical startups? ... The biopharmaceutical industry accounts for ...
(Date:7/17/2017)... , July 17, 2017  MedX Holdings, Inc., ... medical testing, strengthening and rehabilitation equipment, today announced the ... Program. MedX is considered the gold standard for the ... in specialized medical strengthening equipment. ... lease with the physician or practice who prescribe the ...
(Date:7/14/2017)... LAS VEGAS , July 13, 2017 It ... the United States is in the midst of ... Disease Control , since 1999, the number of overdose deaths ... , "resulting in over half a million dead from 2001 ... like codeine, oxycodone, and hydrocodone has similarly quadrupled, drawing a ...
Breaking Medicine Technology:
(Date:7/27/2017)... ... July 27, 2017 , ... MAP Health Management, LLC., ... Fierce Innovation Awards: Healthcare Edition 2017, an awards program from the publisher of ... Health Management/Patient Engagement Solutions. , MAP was selected as a finalist for ...
(Date:7/27/2017)... ... July 27, 2017 , ... Team Novo Nordisk, the world’s first all-diabetes ... pro squad as a stagiaire for the remainder of the 2017 season. One of ... 31st at the Tour of Utah. , “Every season we are excited to move ...
(Date:7/27/2017)... York, NY (PRWEB) , ... July 27, 2017 ... ... to President Barack Obama from 2012-2016, will keynote Day 2 of the HIMSS ... The event kicks off at the Sheraton Boston Hotel, Sept. 11-13, 2017. , ...
(Date:7/26/2017)... , ... July 26, 2017 , ... Capillus, LLC has ... hereditary hair loss. The new Flexible Fitting Design offers a more comfortable, adaptable fit ... is delighted with the improvements to the home-use laser therapy caps intended to improve ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... Six greater Bay Area roller derby leagues ... “Make ‘em Bleed,” the most widely attended series of blood drives in California, beginning July ... blood over the past 4 years -- enough to have helped to save up to ...
Breaking Medicine News(10 mins):